Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Benzimidazole derivatives: A versatile scaffold for drug development against Helicobacter pylori-related diseases.

Authors:
Hedieh Rostami Mohammad Hossein Haddadi

Fundam Clin Pharmacol 2022 Jun 18. Epub 2022 Jun 18.

Clinical Microbiology Research Centre, Ilam University of Medical Sciences, Ilam, Iran.

Helicobacter pylori (H. pylori) is a microaerophilic gastric pathogen and a major contributor to chronic atrophic gastritis, peptic ulcer, and gastric malignancies. The increasing prevalence of H. pylori infection and its related diseases, such as gastric cancer (GC), motivates medicinal chemists to seek for more effective multi-targeting drugs to prevent and treat H. pylori-related clinical complications. Benzimidazole, a hetero-aromatic bicyclic ring compound, has claimed a prominent role in medicinal chemistry owing to its broad range of biological activities, including antibacterial, antiviral, antidiabetic, and anticancer activities. Studies highlight the promising therapeutic potential of benzimidazole derivatives in the treatment of H. pylori-related clinical complications such as gastric infection, gastritis, peptic ulcer, and GC. Accordingly, we here aimed to scrutinize the role of active molecules of benzimidazole derivatives as potential antibacterial, anti-urease, anti-inflammatory, anti-ulcerative, and anticancer agents, which are expected to find their ways to the clinical setting sooner or later. Due to the role of structural moieties in determining the biological behaviors of benzimidazole derivatives, we explored the structure-activity relationship (SAR) of these compounds to further expand the scope of design of and research on new drugs against H. pylori-related diseases.

Download full-text PDF

Source
http://dx.doi.org/10.1111/fcp.12810DOI Listing
June 2022

Publication Analysis

Top Keywords

benzimidazole derivatives
16
h pylori-related clinical
8
gastritis peptic
8
clinical complications
8
peptic ulcer
8
benzimidazole
5
compounds expand
4
activities including
4
complications gastric
4
treatment h pylori-related
4
derivatives treatment
4
potential benzimidazole
4
therapeutic potential
4
promising therapeutic
4
highlight promising
4
studies highlight
4
activities studies
4
anticancer activities
4
antidiabetic anticancer
4
antiviral antidiabetic
4

Keyword Occurance

Similar Publications

Structure-Based Design of Xanthine-Benzimidazole Derivatives as Novel and Potent Tryptophan Hydroxylase Inhibitors.

Authors:
Edgar Specker Susann Matthes Radoslaw Wesolowski Anja Schütz Maik Grohmann Natalia Alenina Dirk Pleimes Keven Mallow Martin Neuenschwander Angelina Gogolin Marie Weise Jochen Pfeifer Nandor Ziebart Udo Heinemann Jens Peter von Kries Marc Nazaré Michael Bader

J Med Chem 2022 Aug 3. Epub 2022 Aug 3.

Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC), Robert-Rössle-Str. 10, 13125 Berlin-Buch, Germany.

Tryptophan hydroxylases catalyze the first and rate-limiting step in the synthesis of serotonin. Serotonin is a key neurotransmitter in the central nervous system and, in the periphery, functions as a local hormone with multiple physiological functions. Studies in genetically altered mouse models have shown that dysregulation of peripheral serotonin levels leads to metabolic, inflammatory, and fibrotic diseases. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Novel compound shows in vivo anthelmintic activity in gerbils and sheep infected by Haemonchus contortus.

Authors:
Elora Valderas-García Nerea Escala María Álvarez-Bardón Verónica Castilla-Gómez de Agüero Maria Cambra-Pellejà Laura González Del Palacio Raquel Vallejo García Jennifer de la Vega Arturo San Feliciano Esther Del Olmo María Martínez-Valladares Rafael Balaña-Fouce

Sci Rep 2022 Jul 29;12(1):13004. Epub 2022 Jul 29.

Departamento de Ciencias Biomédicas, Facultad de Veterinaria, Universidad de León, 24071, León, Spain.

The control of gastrointestinal nematodes in livestock is becoming increasingly difficult due to the limited number of available drugs and the rapid development of anthelmintic resistance. Therefore, it is imperative to develop new anthelmintics that are effective against nematodes. Under this context, we tested the potential toxicity of three compounds in mice and their potential anthelmintic efficacy in Mongolian gerbils infected with Haemonchus contortus. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Structure-Activity Relationship of New Chimeric Analogs of Mastoparan from the Wasp Venom .

Authors:
Jarosław Ruczyński Brygida Parfianowicz Piotr Mucha Katarzyna Wiśniewska Lidia Piechowicz Piotr Rekowski

Int J Mol Sci 2022 Jul 27;23(15). Epub 2022 Jul 27.

Laboratory of Chemistry of Biologically Active Compounds, Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308 Gdańsk, Poland.

Mastoparan (MP) is an antimicrobial cationic tetradecapeptide with the primary structure INLKALAALAKKIL-. This amphiphilic α-helical peptide was originally isolated from the venom of the wasp . MP shows a variety of biological activities, such as inhibition of the growth of Gram-positive and Gram-negative bacteria, as well as hemolytic activity and activation of mast cell degranulation. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Highly Active Cyclic Zinc(II) Thione Catalyst for C-C and C-N Bond Formation Reactions.

Authors:
Maruthupandi Mannarsamy Muneshwar Nandeshwar Gopendra Muduli Ganesan Prabusankar

Chem Asian J 2022 Jul 26. Epub 2022 Jul 26.

Indian Institute of Technology-Hyderabad, Chemistry, Kandi Medak Telangana India 502285, 502285, 502285, Hyderabad, INDIA.

The first discrete seven-membered cyclic zinc(II) complex catalyzed room temperature Knoevenagel condensation reactions, and the synthesis of perimidine derivatives has been reported under mild reaction conditions. The cyclic zinc(II) complex [( L) ZnBr 2 ] ( 1 ) was isolated from the reaction between 1-(2-hydroxyethyl)-3-isopropyl-benzimidazole-2-thione ( L ) and ZnBr 2 . Complex 1 was characterized by different analytic techniques such as FT-IR, CHNS, TGA, NMR, and SCXRD. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Structural insights revealed by the cocrystal structure of CCS1477 in complex with CBP bromodomain.

Authors:
Hongrui Xu Guolong Luo Tianbang Wu Jiankang Hu Chao Wang Xishan Wu Yan Zhang Yong Xu Qiuping Xiang

Biochem Biophys Res Commun 2022 Jul 16;623:17-22. Epub 2022 Jul 16.

Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, 315000, China; Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, 315000, China. Electronic address:

Inhibition of the bromodomain of the CREB (cyclic-AMP response element-binding protein) binding protein (CBP) is a particularly promising new therapeutic approach for cancer. Benzimidazole derivatives CCS1477 and its analogues (8 and 9) are highly potent and selective CBP bromodomain inhibitors, with K values of 26.4, 37. Read More

View Article and Full-Text PDF
July 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap